NCT04947722Active, not recruiting
The PREVENT Trial: a Pragmatic Cluster Randomized Controlled Trial of a Multifaceted Fracture Prevention Model for Long-term Care
Source: ClinicalTrials.gov · Last updated 13 Jul 2026
Brief summary (registry, in English)
Hip fractures occur nearly twice as often for older adults residing in long-term care as they do in older adults of a similar age still living in other settings. Hip fractures are the leading cause of hospitalization and often result in loss of independence, problems with walking and sometimes death. To address this problem the PREVENT (Person-centered Routine Fracture PrEVENTion in LTC) program was designed for use in long-term care homes. PREVENT uses a tool ("fracture risk calculator") based on a residents electronic health record to capture who is most at risk of fracture due to osteoporosis and falls. The program then trains the health care team including doctors, pharmacists and nurses on the latest recommendations on how to best assist residents and their families in making treatment decisions. The healthcare teams are also given tools that help them stay on track such as templates for ordering medications, strategies to reduce falls and fractures and making care plans. The study will examine if this program is effective for decreasing hip fractures by assigning some homes to receive the PREVENT program (intervention group) and some homes to usual care (control group) and comparing the results.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 3060 (estimated)
- First submitted
- 24 Jun 2021
- Start date
- 19 Jun 2024
- Primary completion date
- 31 Mar 2027
- Lead sponsor
- McMaster University
- Diseases
- Osteoporosis
- NCT number
- NCT04947722
What you commit to
- Study type: Interventional
- Planned participants: 3060
- From 19 Jun 2024 to the primary completion date, 31 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Residents identified as having end-stage disease, who are comatose, receiving hospice or respite care and who have an expected short stay (90 days or less).
Who the study is looking for
- Both profit and non-profit long-term care homes in Ontario, Canada.
- Homes must have a minimum of 50 occupied beds to participate; there is no maximum home size for participation.
- For both control and intervention homes, resident eligibility (and study cohorts) will be determined via the RAI-MDS 2.0 database.
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| McMaster University - St. Peter's Hospital Coordinator of this site? Confirm its status | Hamilton | Canada | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.